Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRocView Video
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investorsView Video

Latest Share Chat

EU approves J&J Covid-19 vaccine for use in people 18 and over

Thu, 11th Mar 2021 14:01

(Sharecast News) - Europe's main drugs regulator gave the green-light to Johnson&Johnson's Covid-19 vaccine, a move that it was hoped would help the bloc accelerate its inoculation programme.
The European Medicines Agency recommended the vaccine for use in people aged 18 and over.

J&J's vaccine has two key advantages over those of rivals, including the fact that it only requires a single dose and that it can be stored for long periods in normal refrigerators.

Brussels had bought 200.0m doses with an option to double that number.

However, there were now doubts about whether J&J would begin shipments in April, as previously announced by the European Commission.

Indeed, the drug giant had reportedly yet to provide a delivery schedule for its vaccine.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.